Q&A: Marching for Science in San Francisco

A conversation with startup founder and chemist Amado Guloy

Written byTracy Vence
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

Speaking at a TechCrunch eventCOURTESY OF AMADO GULOYA materials and inorganic chemist by training, Amado Guloy is now dedicating 30 to 40 hours a week organizing a March for Science in San Francisco. As founder and chief executive officer of Rex Animal Health, which offers a “23andme-type test to look at the health and wellbeing of [livestock] animals,” Guloy was concerned when he saw reports of research restrictions and gag orders at the US Environmental Protection Agency (EPA) and Department of Agriculture (USDA). “We do have some slight commercial interests in ensuring those agencies are not silenced when it comes to science,” he said. But his reason for planning a march, he said, was more than personal. “This is about raising awareness,” Guloy told The Scientist: “This is what science has done, this is why data is important.”

The Scientist: What prompted you to take the lead in organizing a satellite march in San Francisco?

Amado Guloy: We have an executive committee of a dozen people strong now . . . I’m acting as chair because, in running companies, you have to know how to be organized and put together people, so that was one of the things I brought to the table.

I got involved initially through the Reddit group, when people were talking about it [the March for Science in DC], I was like, Alright, this makes sense. Especially for me, I was worried about the silencing of the USDA and the EPA. . . . When people started organizing [nationwide], I said, Alright, well I’m in San Francisco, let’s do ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies